Cargando…

Combined Use of Ninjin'yoeito Improves Subjective Fatigue Caused by Lenalidomide in Patients With Multiple Myeloma: A Retrospective Study

Lenalidomide is an immunomodulating derivative of thalidomide, which shows anti-tumor activity against myeloma cells with immunomodulation including augmentation of T-cell and natural killer cell function. Continuous treatment with this agent shows better survival benefit in patients with multiple m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ito, Tomoki, Konishi, Akiko, Tsubokura, Yukie, Azuma, Yoshiko, Hotta, Masaaki, Yoshimura, Hideaki, Nakanishi, Takahisa, Fujita, Shinya, Nakaya, Aya, Satake, Atsushi, Ishii, Kazuyoshi, Nomura, Shosaku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Nutrition
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110850/ https://www.ncbi.nlm.nih.gov/pubmed/30186837 http://dx.doi.org/10.3389/fnut.2018.00072

Ejemplares similares

Secondary pure red cell aplasia in multiple myeloma treated with lenalidomide
por: Ito, Tomoki, et al.
Publicado: (2018)

A Clinical Study of Ninjin'yoeito With Regard to Frailty
por: Sakisaka, Naoya, et al.
Publicado: (2018)

Herbal Medicine Ninjin'yoeito in the Treatment of Sarcopenia and Frailty
por: Uto, Nanami Sameshima, et al.
Publicado: (2018)

Improvement of Diabetes Mellitus Symptoms by Intake of Ninjin'yoeito
por: Hosogi, Shigekuni, et al.
Publicado: (2018)

Analysis of the Effects of Ninjin’yoeito on Physical Frailty in Mice
por: Otsuka, Shotaro, et al.
Publicado: (2022)

Ninjin’yoeito Improves Genitourinary Symptoms in Patients With Frailty
por: Okui, Nobuo, et al.
Publicado: (2023)

Transplant-Ineligible Symptomatic but Indolent Multiple Myeloma Shows Better Prognosis with Conventional Agents
por: Nakaya, Aya, et al.
Publicado: (2017)

Dasatinib-induced hemorrhagic colitis complicated with cytomegalovirus infection
por: Nakaya, Aya, et al.
Publicado: (2017)

Blastic Epstein-Barr virus associated post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation for severe aplastic anemia
por: Hotta, Masaaki, et al.
Publicado: (2018)

Human T-cell Leukemia Virus Type I Associated with an Increased Risk of Primary Malignant Neoplasm
por: Nakaya, Aya, et al.
Publicado: (2018)

Safety and Effectiveness of Ninjin'yoeito: A Utilization Study in Elderly Patients
por: Suzuki, Shinichi, et al.
Publicado: (2019)

Case Report: Efficacy of Ninjin'yoeito Treatment for Idiopathic Pulmonary Fibrosis
por: Kushima, Hisako, et al.
Publicado: (2021)

Enhanced international prognostic index in Japanese patients with diffuse large B-cell lymphoma
por: Nakaya, Aya, et al.
Publicado: (2016)

Clinical significance of dasatinib-induced pleural effusion in patients with de novo chronic myeloid leukemia
por: Nakaya, Aya, et al.
Publicado: (2018)

Impact of CRAB Symptoms in Survival of Patients with Symptomatic Myeloma in Novel Agent Era
por: Nakaya, Aya, et al.
Publicado: (2017)

Evaluation of eltrombopag in patients with aplastic anemia in real-world experience
por: Konishi, Akiko, et al.
Publicado: (2019)

Neutrophil-to-lymphocyte ratio (NLR) fails to predict outcome of diffuse large B cell lymphoma
por: Azuma, Yoshiko, et al.
Publicado: (2019)

Retrospective analysis of adolescent and young adult with lymphoma at two cancer facilities in Japan
por: Nakaya, Aya, et al.
Publicado: (2019)

Evaluation of azacitidine in patients with transplant-ineligible myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changes in a Japanese clinical setting
por: Nakaya, Aya, et al.
Publicado: (2020)

Trend of salvage treatment in diffuse large B cell lymphoma in the outpatient chemotherapy era
por: Nakaya, Aya, et al.
Publicado: (2019)

Effect of Ninjin’yoeito on the Loss of Skeletal Muscle Function in Cancer-Bearing Mice
por: Ohsawa, Masahiro, et al.
Publicado: (2018)

Ninjin'yoeito Alleviates Neuropathic Pain Induced by Chronic Constriction Injury in Rats
por: Takemoto, Risa, et al.
Publicado: (2021)

Tyrosine kinase inhibitor and rituximab‐CHOP treatment for concurrent chronic myeloid leukemia and non‐Hodgkin lymphoma: a case report
por: Takeyasu, Yuki, et al.
Publicado: (2017)

Perspectives on the Use of Ninjin'yoeito in Modern Medicine: A Review of Randomized Controlled Trials
por: Takayama, Shin, et al.
Publicado: (2019)

Maintaining Weight and Nutritional Status with Ninjin’yoeito in Elderly Patients with Chronic Wasting Diseases
por: Nakagawa, Yumi, et al.
Publicado: (2022)

Impact of Ninjin’yoeito on frailty and short life in klotho-hypomorphic (kl/kl) mice
por: Amitani, Haruka, et al.
Publicado: (2022)

Disseminated intravascular coagulation observed following treatment with gemtuzumab ozogamicin for relapsed/refractory acute promyelocytic leukemia
por: AZUMA, YOSHIKO, et al.
Publicado: (2016)

Influence of Intragastric Administration of Traditional Japanese Medicine, Ninjin'Yoeito, on Cerebral Blood Flow via Muscarinic Acetylcholine Receptors
por: Watanabe, Nobuhiro, et al.
Publicado: (2021)

Mogamulizumab treatment of refractory peripheral T-cell lymphoma following autologous stem cell transplantation: A case report
por: FUJITA, YUKIE, et al.
Publicado: (2016)

Myodesopsia is a symptom of central nervous system blast crisis in chronic myeloid leukemia
por: Ishii, Kazuyoshi, et al.
Publicado: (2019)

Efficacy of Ninjin'yoeito in treating severe coronavirus disease 2019 in patients in an intensive care unit
por: Aomatsu, Naoki, et al.
Publicado: (2021)

Ninjin’yoeito suppressed the onset of arthritis, pain, and muscle atrophy in rheumatoid arthritis model mice
por: Suginohara, Takeshi, et al.
Publicado: (2022)

Effects of Ninjin'yoeito on Human CYP3A and Mouse CYP3A Activity
por: Kaneda, Marisa, et al.
Publicado: (2023)

A variant of acute promyelocytic leukemia with t(4;17)(q12;q21) showed two different clinical symptoms
por: Nakanishi, Takahisa, et al.
Publicado: (2019)

Japanese Kampo medicine ninjin'yoeito synergistically enhances tumor vaccine effects mediated by CD8(+) T cells
por: Takaku, Shun, et al.
Publicado: (2017)

Case Report: Ninjin'yoeito May Improve Quality of Life After Hospitalization for Acute Illness in Patients With Frailty
por: Kashima, Masayuki
Publicado: (2021)

Evaluation of a biosimilar granulocyte colony-stimulating factor (filgrastim XM02) for peripheral blood stem cell mobilization and transplantation: a single center experience in Japan
por: Yoshimura, Hideaki, et al.
Publicado: (2017)

Evaluation of thrombosis-related biomarkers before and after therapy in patients with multiple myeloma
por: Nomura, Shosaku, et al.
Publicado: (2018)

Improvement in Frailty in a Patient With Severe Chronic Obstructive Pulmonary Disease After Ninjin'yoeito Therapy: A Case Report
por: Kuniaki, Hirai, et al.
Publicado: (2018)

Ninjin'yoeito Targets Distinct Ca(2+) Channels to Activate Ghrelin-Responsive vs. Unresponsive NPY Neurons in the Arcuate Nucleus
por: Goswami, Chayon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9vd61pjnd5o3jhi0cpvo7fddp6